Krónikus mieloid leukémia (CML): vizsgálatok itt: Dél-Korea
10 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Seoul
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Busan, Jeollanam, Seoul, Uijeongbu-si
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1/2. fázisTaking peopleA Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Where
- Anyang-si, Busan, Daegu, Uijeongbu-si
- Életkor
- 18 év to 64 év
- People
- 330 worldwide
- Run by
- Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
See details and how to joinNCT06163430 · EU 2023-507677-18-00 - 3. fázisTaking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Busan, Gyeonggi-do, Seoul, Uijeongbu-si
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - 3. fázisTaking peopleA Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
- Where
- Uijeongbu-si
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Il-Yang Pharm. Co., Ltd.
See details and how to joinNCT03459534 - No phaseTaking peopleAsciminib RMP Study
- Where
- Anyang-si, Bucheon-si, Gyeonggi-do, Incheon, Jeollanam, Pusan, Seoul, Suwon, Taegu, Uijeongbu-si, Wŏnju
- Életkor
- 18 év to 100 év
- People
- 600
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05943522 - 2. fázisTaking peopleA Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
- Where
- Incheon
- Életkor
- 19 év and over
- People
- 69
- Run by
- Korean Society of Hematology
See details and how to joinNCT06368414 - 1. fázisTaking peopleA Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Where
- Daegu, Gyeonggi-do, Hwasun, Jeonju, Seoul
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00 - 1/2. fázisFut, nem toborozClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Daegu, Pusan, Seongnam, Seoul
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00